Bacterial News and Research

RSS

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

Protein M is a cell surface protein from Mycoplasma Genitalium that binds to all human antibodies.

26 Feb 2014

Nurses in emergency care must be trained to recognise symptoms of meningococcal septicaemia

Nurses working in emergency care environments must be trained to recognise the atypical signs and symptoms of meningococcal septicaemia.

26 Feb 2014

Microbes are more likely to adhere to tube walls in flowing water

In a surprising new finding, researchers have discovered that bacterial movement is impeded in flowing water, enhancing the likelihood that the microbes will attach to surfaces.

25 Feb 2014

Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Onset Dermatologics, a leader in developing and commercializing prescription products for improving skin health, today announced the launch of a 75mg strength of MINOCIN (minocycline hydrochloride) Pellet-Filled Capsules.

25 Feb 2014

Researchers develop early warning systems for preventing epidemics

The environment has an impact on our health. Preventing epidemics relies on activating the right counter-measures, and scientists are now trying to find out how better use of forecasting can help.

24 Feb 2014

University of Texas researchers reveal ancient mysteries behind leprosy

Research at The University of Texas MD Anderson Cancer Center is finally unearthing some of the ancient mysteries behind leprosy, also known as Hansen's disease, which has plagued mankind throughout history.

21 Feb 2014

Wiley partners with Bergey's Trust to publish Bergey's Manual of Systematics of Archaea and Bacteria

John Wiley & Sons, Inc. announced a new partnership with Bergey's Manual Trust, which will see Wiley publish Bergey's Manual of Systematics of Archaea and Bacteria (BMSAB) from 2014.

21 Feb 2014

Antibiotics prescribed for children who have URIs does not prevent complications

Antibiotics are often prescribed for young children who have upper respiratory tract infections (URIs) in order to prevent complications, such as ear infections and pneumonia, however, a new evidence review in The Cochrane Library found no evidence to support this practice.

19 Feb 2014

Taste receptors act as first line sentinels against infection in upper airway

The body uses mucus as a protective barrier to defend against pathogens, toxins, and allergens in the upper respiratory tract that can lead to such conditions as chronic sinusitis.

19 Feb 2014

Scientists propose improved method of screening salmonella vaccines in small animal studies

An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines or RASVs can be perfected, they hold the promise of safe, lost-cost, orally administered defenses against viral, bacterial, fungal and parasitic infections.

19 Feb 2014

New research reveals link between BMI and amount of bacteria colonizing noses

Do attractive traits tell us anything about a person's reproductive health? New research in the American Journal of Human Biology reveals a link between Body Mass Index (BMI) and the amount of bacteria colonizing noses.

19 Feb 2014

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.

14 Feb 2014

University of Liège joins IMI programme to develop new antibiotics against Gram-negative pathogens

More than 30 European universities and companies, led by GlaxoSmithKline, are joining forces in a six-year programme funded by the Innovative Medicines Initiative (IMI) for the sum of EUR 85 millions with the aim of developing new antibiotics against Gram-negative pathogens.

14 Feb 2014

Two new mechanisms open alternative approaches to antibiotics development

The first mechanism disrupts the arrangement of amino acids required for the cohesion of the protease subunits. As a result the protease breaks into two parts. The second acts directly on the core of the active center.

14 Feb 2014

Researchers discover how beneficial bacteria in guts communicate with own cells

Communication is vital to any successful relationship. Researchers from the Institute of Food Research and the University of East Anglia have discovered how the beneficial bacteria in our guts communicate with our own cells.

14 Feb 2014

Study uncovers how gut bacteria metabolize complex dietary carbohydrates in fruits, vegetables

We are all aware of the health benefits of dietary fiber. But what is dietary fiber and how do we metabolize it?

13 Feb 2014

Drive for novel antibiotics against gram-negative bacteria

Over 30 European universities, research institutes, and companies, led by GlaxoSmithKline and Uppsala University, are joining forces in a 6 year programme supported by the Innovative Medicines Initiative (IMI) to develop novel antibiotics against Gram-negative pathogens.

13 Feb 2014

Researchers examine how evolution relates to health

February 12 marks the birth of the 19th century naturalist Charles Darwin, who launched the scientific study of evolution. While Darwin's theory laid the groundwork, ongoing studies have deepened our understanding of evolution, including how it relates to health. Research funded by the National Institutes of Health has helped answer many questions about evolution, health and medicine. Here's a sampling.

12 Feb 2014

Researchers shed new light on pain associated with bacterial infections

Components in the outer wall of bacteria directly activate pain sensors, triggering immediate pain and inflammatory responses. This finding by a multinational team of researchers led by Professor Karel Talavera (KU Leuven, Belgium) and Professor Félix Viana (Institute of Neuroscience, Spain) sheds new light on pain associated with bacterial infections and reveals a new target for drugs designed to treat them.

11 Feb 2014

Novel combined therapy for treatment of septic patients in ICU

Septic shock is caused by excessive and systemic reaction of the entire body against infectious agents, in most cases of bacterial origin. The number of deaths by septic shock in intensive care units is very high and is still increasing, despite numerous large scale clinical trials.

9 Feb 2014

Bacterial News and Research

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

Nurses in emergency care must be trained to recognise symptoms of meningococcal septicaemia

Microbes are more likely to adhere to tube walls in flowing water

Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Researchers develop early warning systems for preventing epidemics

University of Texas researchers reveal ancient mysteries behind leprosy

Wiley partners with Bergey's Trust to publish Bergey's Manual of Systematics of Archaea and Bacteria

Antibiotics prescribed for children who have URIs does not prevent complications

Taste receptors act as first line sentinels against infection in upper airway

Scientists propose improved method of screening salmonella vaccines in small animal studies

New research reveals link between BMI and amount of bacteria colonizing noses

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

University of Liège joins IMI programme to develop new antibiotics against Gram-negative pathogens

Two new mechanisms open alternative approaches to antibiotics development

Researchers discover how beneficial bacteria in guts communicate with own cells

Study uncovers how gut bacteria metabolize complex dietary carbohydrates in fruits, vegetables

Drive for novel antibiotics against gram-negative bacteria

Researchers examine how evolution relates to health

Researchers shed new light on pain associated with bacterial infections

Novel combined therapy for treatment of septic patients in ICU

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News